Tracking the tissue distribution of marker dye following intranasal delivery in mice and chinchillas: a multifactorial analysis of parameters affecting nasal retention

被引:54
作者
Visweswaraiah, A
Novotny, LA
Hjemdahl-Monsen, EJ
Bakaletz, LO
Thanavala, Y
机构
[1] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA
[2] Ohio State Univ, Div Mol Med, Childrens Res Inst, Columbus, OH 43210 USA
关键词
biodistribution; intranasal immunization; targeted delivery;
D O I
10.1016/S0264-410X(02)00247-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The combined mucosal surface area is vast and represents the primary site of entry of most pathogens to the respiratory, gastrointestinal (GI), and urogenital tracts. It is recognized that vaccines delivered parenterally typically only induce weak mucosal immune responses and that by targeting the mucosal immune system protective antibodies and effector lymphocytes could be induced at the primary site of infection. In the present study, we have evaluated an extensive set of conditions required to ensure maximum retention of intranasally administered substances within the nasal cavity in the chinchilla and murine hosts. We report here that many parameters, such as anaesthesia, position of animal during and post delivery, and dosing schedule, must be optimized in concert with each other and that results from one species cannot be extrapolated directly to another animal model. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:3209 / 3220
页数:12
相关论文
共 51 条
[1]   Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection [J].
Bakaletz, LO ;
Kennedy, BJ ;
Novotny, LA ;
Duquesne, G ;
Cohen, J ;
Lobet, Y .
INFECTION AND IMMUNITY, 1999, 67 (06) :2746-2762
[2]   Monophosphoryl lipid A enhances mucosal and systemic immunity to vaccine antigens following intranasal administration [J].
Baldridge, JR ;
Yorgensen, Y ;
Ward, JR ;
Ulrich, JT .
VACCINE, 2000, 18 (22) :2416-2425
[3]  
BALLOU R, 1998, TECHN REV GROUP M GE, P43
[4]   Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions [J].
Balmelli, C ;
Roden, R ;
Potts, A ;
Schiller, J ;
De Grandi, P ;
Nardelli-Haefliger, D .
JOURNAL OF VIROLOGY, 1998, 72 (10) :8220-8229
[5]   Intranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization [J].
Barackman, JD ;
Ott, G ;
O'Hagan, DT .
INFECTION AND IMMUNITY, 1999, 67 (08) :4276-4279
[6]   The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice [J].
Barchfeld, GL ;
Hessler, AL ;
Chen, M ;
Pizza, M ;
Rappuoli, R ;
Van Nest, GA .
VACCINE, 1999, 17 (7-8) :695-704
[7]   Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine [J].
Berstad, AKH ;
Andersen, SR ;
Dalseg, R ;
Dromtorp, S ;
Holst, J ;
Namork, E ;
Wedege, E ;
Haneberg, B .
VACCINE, 2000, 18 (18) :1910-1919
[8]   Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans [J].
Brady, LJ ;
van Tilburg, MLJA ;
Alford, CE ;
McArthur, WP .
INFECTION AND IMMUNITY, 2000, 68 (04) :1796-1805
[9]   Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen [J].
Childers, NK ;
Miller, KL ;
Tong, G ;
Llarena, JC ;
Greenway, T ;
Ulrich, JT ;
Michalek, SM .
INFECTION AND IMMUNITY, 2000, 68 (10) :5509-5516
[10]  
COLUMBO JL, 1993, PEDIAT RESP DIS DIAG, P429